• Reuters reporting that several drug makers will announce a pricing agreement with the US today.
• AbbVie, Bristol Myers Squibb, Merck & Co are mentioned.
• Novartis and Roche were mentioned yesterday and again today.
• Pfizer, Eli Lilly, AstraZeneca, Novo Nordisk and Merck KGaA have already announced deals.
Find more articles and bullets on these widgets:
Bloomberg reports that primary dealers pushed back against Fed officials urging them to use a key borrowing facility at a meeting last week, complicating efforts to ease strains in the $12 trillion market for repurchase agreements. See the full report here.
Note that gilt bears still haven’t filled the gap lower in 30-Year yields that came on October 14. The benchmark is now 27bp off month-to-date lows at 5.41% vs. session highs of 5.431%. They would have to push the benchmark to 5.463% to close the aforementioned gap.
| Type | 3-month EU-bill | 6-month EU-bill | 12-month EU-bill |
| Maturity | Feb 6, 2026 | May 8, 2026 | Nov 6, 2026 |
| Amount | E827mln | E852mln | E801mln |
| Target | E1.0bln | E1.0bln | E1.0bln |
| Previous | E816mln | E852mln | E1.16bln |
| Avg yield | 1.958% | 1.991% | 2.020% |
| Previous | 1.953% | 1.977% | 2.012% |
| Bid-to-cover | 2.54x | 2.75x | 2.76x |
| Previous | 1.72x | 1.76x | 1.72x |
| Previous date | Nov 05, 2025 | Nov 05, 2025 | Nov 05, 2025 |